title: CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy.
authors.affiliation: University of Chicago, Illinois.
authors.forename: T M
authors.initials: TM
authors.lastname: Zimmerman
authors.forename: W J
authors.initials: WJ
authors.lastname: Lee
authors.forename: J G
authors.initials: JG
authors.lastname: Bender
authors.forename: R
authors.initials: R
authors.lastname: Mick
authors.forename: S F
authors.initials: SF
authors.lastname: Williams
mesh_terms: D015703:Antigens, CD / Q000378:metabolism*; D018952:Antigens, CD34; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy / Q000628:therapy*; D002452:Cell Count; D003114:Colony-Forming Units Assay; D003131:Combined Modality Therapy; D005260:Female; D006098:Granulocytes; D006410:Hematopoiesis; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects* / Q000276:immunology*; D006801:Humans; D007958:Leukocyte Count; D010976:Platelet Count; D014182:Transplantation, Autologous
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34; D000970:Antineoplastic Agents